Literature DB >> 16514429

Renal albumin absorption in physiology and pathology.

H Birn1, E I Christensen.   

Abstract

Albumin is the most abundant plasmaprotein serving multiple functions as a carrier of metabolites, hormones, vitamins, and drugs, as an acid/base buffer, as antioxidant and by supporting the oncotic pressure and volume of the blood. The presence of albumin in urine is considered to be the result of the balance between glomerular filtration and tubular reabsorption. Albuminuria has been accepted as an independent risk factor and a marker for renal as well as cardiovascular disease, and during the past decade, evidence has suggested that albumin itself may cause progression of renal disease. Thus, the reduction of proteinuria and, in particular, albuminuria has become a target in itself to prevent deterioration of renal function. Studies have shown albumin and its ligands to induce expression of inflammatory and fibrogenic mediators, and it has been hypothesized that increased filtration of albumin causes excessive tubular reabsorption, resulting in inflammation and fibrosis, resulting in the loss of renal function. In addition, it is known that tubular dysfunction in itself may cause albuminuria owing to decreased reabsorption of filtered albumin, and, recently, it has been suggested that significant amounts of albumin fragments are excreted in the urine as a result of tubular degradation. Thus, although both tubular and glomerular dysfunction influences renal handling of albumin, it appears that tubular reabsorption plays a central role in mediating the effects of albumin on renal function. The present paper will review the mechanisms for tubular albumin uptake and the possible implications for the development of renal disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16514429     DOI: 10.1038/sj.ki.5000141

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  114 in total

1.  BioDMET: a physiologically based pharmacokinetic simulation tool for assessing proposed solutions to complex biological problems.

Authors:  John F Graf; Bernhard J Scholz; Maria I Zavodszky
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-12-10       Impact factor: 2.745

Review 2.  Genome-wide association studies of chronic kidney disease: what have we learned?

Authors:  Conall M O'Seaghdha; Caroline S Fox
Journal:  Nat Rev Nephrol       Date:  2011-12-06       Impact factor: 28.314

3.  Kidney proteome changes provide evidence for a dynamic metabolism and regional redistribution of plasma proteins during torpor-arousal cycles of hibernation.

Authors:  Alkesh Jani; David J Orlicky; Anis Karimpour-Fard; L Elaine Epperson; Rae L Russell; Lawrence E Hunter; Sandra L Martin
Journal:  Physiol Genomics       Date:  2012-05-29       Impact factor: 3.107

4.  Generation of urinary albumin fragments does not require proximal tubular uptake.

Authors:  Kathrin Weyer; Rikke Nielsen; Erik I Christensen; Henrik Birn
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

5.  Altered renal proximal tubular endocytosis and histology in mice lacking myosin-VI.

Authors:  Nanami Gotoh; Qingshang Yan; Zhaopeng Du; Daniel Biemesderfer; Michael Kashgarian; Mark S Mooseker; Tong Wang
Journal:  Cytoskeleton (Hoboken)       Date:  2010-03

Review 6.  CFTR structure and function: is there a role in the kidney?

Authors:  J Souza-Menezes; M M Morales
Journal:  Biophys Rev       Date:  2009-01-17

7.  Relationship between albuminuria and total proteinuria in systemic lupus erythematosus nephritis: diagnostic and therapeutic implications.

Authors:  Daniel J Birmingham; Brad H Rovin; Ganesh Shidham; Michael Bissell; Haikady N Nagaraja; Lee A Hebert
Journal:  Clin J Am Soc Nephrol       Date:  2008-05-01       Impact factor: 8.237

8.  Evaluation of a 99mTc-labeled AnnexinA5 variant for non-invasive SPECT imaging of cell death in liver, spleen and prostate.

Authors:  Rick Greupink; Charles F Sio; Antwan Ederveen; Joke Orsel
Journal:  Pharm Res       Date:  2009-09-25       Impact factor: 4.200

Review 9.  Where does albuminuria come from in diabetic kidney disease?

Authors:  Wayne D Comper; Leileata M Russo
Journal:  Curr Diab Rep       Date:  2008-12       Impact factor: 4.810

10.  Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case-Control Study.

Authors:  William R Zhang; Timothy E Craven; Rakesh Malhotra; Alfred K Cheung; Michel Chonchol; Paul Drawz; Mark J Sarnak; Chirag R Parikh; Michael G Shlipak; Joachim H Ix
Journal:  Ann Intern Med       Date:  2018-10-23       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.